News
During the Fifth Edition of Africa Health ExCon 2026 EDA Supports Strategic Partnerships to Localize Vaccine Manufacturing and Strengthen Health Security Across Africa
Dr. Ali El-Ghamrawy, Chairman of the Egyptian Drug Authority (EDA), participated in the signing ceremonies of several strategic partnerships aimed at supporting the localization of vaccine manufacturing and advancing biotechnology transfer. These partnerships seek to strengthen health security systems and enhance pharmaceutical manufacturing capabilities in Egypt and across the African continent.
The signing ceremonies were attended by H.E. Prof. Dr. Khaled Abdel Ghaffar, Minister of Health and Population; Dr. Hisham Stait, Chairman of the Egyptian Authority for Unified Procurement (UPA); Prof. Dr. Amr Kandeel, Deputy Minister of Health and Population; Dr. Naeema Al-Gasseer, World Health Organization (WHO) Representative in Egypt; and Dr. Abebe Genetu Bayih, Representative of the Africa Centres for Disease Control and Prevention (Africa CDC), alongside senior officials from national entities and international partners.
The signed partnerships encompass cooperation in technology transfer and vaccine manufacturing, as well as collaboration in research, analytical support, and clinical studies. These efforts are expected to accelerate the localization of vaccine and biological product manufacturing while strengthening the healthcare sector’s preparedness to address current and future health challenges.
The Egyptian Drug Authority emphasizes that localizing the manufacturing of vaccines and biological products remains one of Egypt’s top priorities, serving as a fundamental pillar for achieving sustainable health security. The Authority continues to implement an integrated vision aimed at building advanced manufacturing capabilities capable of competing at both regional and international levels in this strategic sector.
The Authority is also working to deepen local manufacturing and facilitate the transfer of advanced vaccine technologies in line with global developments, supporting Egypt’s ability to secure its strategic needs for high-quality biological products.
Furthermore, the EDA continues to promote regional integration with African countries in the field of biopharmaceutical industries through sustainable partnerships based on knowledge exchange and regulatory harmonization. These efforts contribute to strengthening continental health security and reducing dependence on imports of strategic biological products.
The Egyptian Drug Authority reaffirms its commitment to continuously developing its regulatory and supervisory framework in accordance with the latest international standards. These efforts support innovation, investment, and technology transfer while reinforcing Egypt’s position as a leading regional hub for vaccine and biopharmaceutical manufacturing and advancing sustainable health security across Africa.
Tags
Africa Health ExCon 2026
Strategic Partnerships